![outset medical ceo outset medical ceo](https://www.outsetmedical.com/wp-content/uploads/Steve-Williamson-Outset-Medical-e1610642240898.jpg)
(Outset or the Company) (NASDAQ: OM) on behalf of Outset stockholders.
![outset medical ceo outset medical ceo](https://hoeferwelker.com/wp-content/uploads/2020/04/HURL-1754-980x1307.jpg)
Using sensor-based automation, wireless data transmission and a touchscreen interface, Tablo allows patients to set up and monitor their own treatment independently without relying on clinic staff. SAN JOSE, Calif.(BUSINESS WIRE)Outset Medical a dialysis technology innovator, today announced the appointment of Jean-Olivier Racine as Chief Technology Officer. NEW YORK(BUSINESS WIRE)ActionBragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Outset Medical, Inc.
![outset medical ceo outset medical ceo](https://cdn.theorg.com/7151bf57-1e69-43ef-85fa-14b2e5d25cd2_small.jpg)
Led by Leslie Trigg, CEO, Outset provides the Tablo™ Hemodialysis System, a CE-marked and FDA-cleared novel dialysis system that can be used across a range of clinical settings from dialysis clinics to hospitals and skilled nursing facilities. CEO of Outset Medical Inc (30-Year Financial, Insider Trades) Leslie Trigg (insider trades) sold 15,000 shares of OM on at an average price of 55 a share. (Nasdaq: OM) (Outset), a dialysis technology innovator, today announced the appointment of Jean-Olivier Racine as Chief Technology Officer. The company will use proceeds from the financing to expand the commercial introduction of the Tablo System in acute and chronic care markets in the United States. Medtech Insight spoke with Outset Medical’s CEO Leslie Trigg about lessons learned in her career growing medtechs and her plans for growing Tablo hemodialysis for acute and home care. Former Head of Engineering and Science for Health AI at Amazon Web Services Joins Dialysis Technology Innovation Leader. Rowe Price Associates, Inc., with participation from existing investors Fidelity Management & Research Company, Partner Fund Management LP, Warburg Pincus, Perceptive Advisors and The Vertical Group. WASHINGTON, DC The Medical Device Manufacturers Association (MDMA) announced today that Leslie Trigg, Outset Medical Chair and CEO, was elected as the new Chair of the MDMA Board of Directors during the 2022 Annual Meeting.
#Outset medical ceo series#
Outset Medical, a San Jose, CA-based commercial-stage company delivering technology into the global dialysis market, raised $76.5m in Series C equity funding. MDMA Announces Leslie Trigg, Outset Medical CEO, as New Chair.